Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | renin | Starlite/ChEMBL | References |
Bos taurus | Cathepsin D | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium berghei | plasmepsin X | Cathepsin D | 390 aa | 354 aa | 27.7 % |
Plasmodium yoelii | Eukaryotic aspartyl protease, putative | Cathepsin D | 390 aa | 354 aa | 27.4 % |
Plasmodium knowlesi | aspartyl protease, putative | Cathepsin D | 390 aa | 378 aa | 26.7 % |
Neospora caninum | hypothetical protein | Cathepsin D | 390 aa | 345 aa | 32.5 % |
Candida albicans | secretory aspartyl proteinase SAP7p | Cathepsin D | 390 aa | 385 aa | 24.4 % |
Schistosoma mansoni | memapsin-2 (A01 family) | Cathepsin D | 390 aa | 438 aa | 20.3 % |
Plasmodium falciparum | plasmepsin III | Cathepsin D | 390 aa | 344 aa | 27.0 % |
Candida albicans | secretory aspartyl proteinase SAP10p, related to SAP9p | Cathepsin D | 390 aa | 350 aa | 23.7 % |
Plasmodium yoelii | pepsinogen A-related | Cathepsin D | 390 aa | 387 aa | 25.8 % |
Candida albicans | secretory aspartyl proteinase SAP1p | Cathepsin D | 390 aa | 386 aa | 29.0 % |
Candida albicans | secretory aspartyl proteinase SAP8p | Cathepsin D | 390 aa | 365 aa | 25.8 % |
Plasmodium falciparum | plasmepsin VII | Cathepsin D | 390 aa | 379 aa | 24.0 % |
Candida albicans | secretory aspartyl proteinase SAP2p | Cathepsin D | 390 aa | 378 aa | 27.5 % |
Schistosoma japonicum | Lysosomal aspartic protease precursor, putative | Cathepsin D | 390 aa | 335 aa | 32.5 % |
Brugia malayi | aspartic protease BmAsp-1, identical | Cathepsin D | 390 aa | 406 aa | 29.6 % |
Babesia bovis | aspartyl protease, putative | Cathepsin D | 390 aa | 336 aa | 25.3 % |
Candida albicans | secretory aspartyl proteinase SAP3p | Cathepsin D | 390 aa | 370 aa | 25.9 % |
Candida albicans | secretory aspartyl proteinase SAP4p | Cathepsin D | 390 aa | 370 aa | 27.0 % |
Toxoplasma gondii | aspartyl protease | Cathepsin D | 390 aa | 377 aa | 30.2 % |
Candida albicans | secretory aspartyl proteinase SAP5p | Cathepsin D | 390 aa | 370 aa | 24.9 % |
Plasmodium knowlesi | plasmepsin V, putative | Cathepsin D | 390 aa | 436 aa | 21.8 % |
Toxoplasma gondii | eukaryotic aspartyl protease superfamily protein | Cathepsin D | 390 aa | 383 aa | 25.1 % |
Candida albicans | secretory aspartyl proteinase SAP9p, related to SAP10 | Cathepsin D | 390 aa | 315 aa | 25.1 % |
Candida albicans | secretory aspartyl proteinase SAP5p | Cathepsin D | 390 aa | 370 aa | 24.9 % |
Candida albicans | secretory aspartyl proteinase SAP9p, related to SAP10 | Cathepsin D | 390 aa | 315 aa | 25.1 % |
Onchocerca volvulus | Cathepsin D | 390 aa | 392 aa | 30.1 % | |
Dictyostelium discoideum | hypothetical protein | Cathepsin D | 390 aa | 374 aa | 24.9 % |
Candida albicans | secretory aspartyl proteinase SAP6p | Cathepsin D | 390 aa | 383 aa | 25.8 % |
Babesia bovis | aspartyl protease, putative | Cathepsin D | 390 aa | 339 aa | 31.3 % |
Plasmodium knowlesi | eukaryotic aspartyl protease, putative | Cathepsin D | 390 aa | 350 aa | 29.1 % |
Candida albicans | secretory aspartyl proteinase SAP2p | Cathepsin D | 390 aa | 378 aa | 27.5 % |
Cryptosporidium parvum | secreted pepsinogen like aspartyl protease having a signal peptide | Cathepsin D | 390 aa | 387 aa | 24.0 % |
Onchocerca volvulus | Cathepsin D | 390 aa | 329 aa | 22.5 % | |
Onchocerca volvulus | Putative 6-pyruvoyl tetrahydrobiopterin synthase | Cathepsin D | 390 aa | 395 aa | 30.9 % |
Loa Loa (eye worm) | aspartic protease BmAsp-1 | Cathepsin D | 390 aa | 417 aa | 26.9 % |
Candida albicans | secretory aspartyl proteinase SAP10p, related to SAP9p | Cathepsin D | 390 aa | 350 aa | 23.7 % |
Plasmodium berghei | plasmepsin VII | Cathepsin D | 390 aa | 377 aa | 26.0 % |
Neospora caninum | Cathepsin D enzyme (EC 3.4.23.5), related | Cathepsin D | 390 aa | 376 aa | 27.7 % |
Onchocerca volvulus | Sphingomyelin phosphodiesterase 1 homolog | Cathepsin D | 390 aa | 394 aa | 48.5 % |
Candida albicans | secretory aspartyl proteinase SAP4p | Cathepsin D | 390 aa | 370 aa | 27.0 % |
Plasmodium vivax | aspartyl protease, putative | Cathepsin D | 390 aa | 376 aa | 26.9 % |
Candida albicans | secretory aspartyl proteinase SAP8p | Cathepsin D | 390 aa | 365 aa | 25.8 % |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | Cathepsin D | 390 aa | 388 aa | 33.5 % |
Candida albicans | secretory aspartyl proteinase SAP3p | Cathepsin D | 390 aa | 370 aa | 25.9 % |
Drosophila melanogaster | CG31926 gene product from transcript CG31926-RB | Cathepsin D | 390 aa | 346 aa | 37.9 % |
Plasmodium falciparum | plasmepsin X | Cathepsin D | 390 aa | 351 aa | 28.8 % |
Candida albicans | secretory aspartyl proteinase SAP7p | Cathepsin D | 390 aa | 385 aa | 24.4 % |
Toxoplasma gondii | aspartyl protease ASP3 | Cathepsin D | 390 aa | 345 aa | 32.2 % |
Candida albicans | secretory aspartyl proteinase SAP1p | Cathepsin D | 390 aa | 386 aa | 29.0 % |
Plasmodium falciparum | plasmepsin X | renin | 406 aa | 352 aa | 26.4 % |
Plasmodium falciparum | plasmepsin IX | Cathepsin D | 390 aa | 410 aa | 26.3 % |
Candida albicans | secretory aspartyl proteinase SAP6p | Cathepsin D | 390 aa | 385 aa | 26.0 % |
Plasmodium berghei | plasmepsin IX, putative | Cathepsin D | 390 aa | 403 aa | 25.8 % |
Plasmodium vivax | aspartyl protease, putative | Cathepsin D | 390 aa | 350 aa | 28.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | cathepsin D (A01 family) | 0.0348 | 0.3698 | 0.3698 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.0118 | 0.0348 | 0.0348 |
Trypanosoma brucei | lipase domain protein, putative | 0.0767 | 0.9812 | 1 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.078 | 1 | 1 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0118 | 0.0348 | 1 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0094 | 0 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0118 | 0.0348 | 0.0348 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0172 | 0.114 | 1 |
Plasmodium falciparum | plasmepsin I | 0.0118 | 0.0348 | 1 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.0118 | 0.0348 | 0.5 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0094 | 0 | 0.5 |
Echinococcus granulosus | sn1 specific diacylglycerol lipase beta | 0.0767 | 0.9812 | 0.9812 |
Leishmania major | hypothetical protein, conserved | 0.0767 | 0.9812 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0118 | 0.0348 | 0.0348 |
Schistosoma mansoni | amidase | 0.078 | 1 | 1 |
Onchocerca volvulus | 0.0767 | 0.9812 | 0.5 | |
Plasmodium falciparum | plasmepsin II | 0.0118 | 0.0348 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0767 | 0.9812 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.078 | 1 | 1 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.0118 | 0.0348 | 0.0348 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0348 | 0.3698 | 0.3698 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0767 | 0.9812 | 1 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.0118 | 0.0348 | 0.0348 |
Brugia malayi | Lipase family protein | 0.0767 | 0.9812 | 0.9812 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.078 | 1 | 1 |
Plasmodium falciparum | plasmepsin IV | 0.0118 | 0.0348 | 1 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0094 | 0 | 0.5 |
Plasmodium vivax | plasmepsin IV, putative | 0.0118 | 0.0348 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.078 | 1 | 1 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.078 | 1 | 1 |
Mycobacterium leprae | PROBABLE AMIDASE AMIC (AMINOHYDROLASE) | 0.0094 | 0 | 0.5 |
Echinococcus multilocularis | sn1 specific diacylglycerol lipase beta | 0.0767 | 0.9812 | 0.9812 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.078 | 1 | 1 |
Loa Loa (eye worm) | lipase | 0.0767 | 0.9812 | 0.9812 |
Mycobacterium leprae | PROBABLE GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE (SUBUNIT A) GATA (Glu-ADT SUBUNIT A) | 0.0094 | 0 | 0.5 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0118 | 0.0348 | 0.5 |
Trichomonas vaginalis | lipase containing protein, putative | 0.0767 | 0.9812 | 1 |
Trypanosoma brucei | lipase domain protein, putative | 0.0767 | 0.9812 | 1 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0172 | 0.114 | 1 |
Plasmodium falciparum | plasmepsin VI | 0.0118 | 0.0348 | 1 |
Trichomonas vaginalis | lipase containing protein, putative | 0.0767 | 0.9812 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2.5 nM | In vitro for inhibitory activity against human renin | ChEMBL. | 1956045 |
IC50 (binding) | = 2.5 nM | In vitro for inhibitory activity against human renin | ChEMBL. | 1956045 |
IC50 (binding) | = 13000 nM | In vitro inhibitory activity against bovine Cathepsin D | ChEMBL. | 1956045 |
IC50 (binding) | = 13000 nM | In vitro inhibitory activity against bovine Cathepsin D | ChEMBL. | 1956045 |
IC50 (binding) | = 38500 nM | In vitro inhibitory activity against porcine Pepsin. | ChEMBL. | 1956045 |
IC50 (binding) | = 38500 nM | In vitro inhibitory activity against porcine Pepsin. | ChEMBL. | 1956045 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.